Comparative effectiveness of dapagliflozin <i>vs</i> . empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real‐world prospective cohort study

Tuong Le Trong Huynh, Hien Dieu Tran, Phong Thanh Pham, Nhan Dinh Tran, Nhan Thanh Nguyen, Huyen Doan Thi Bich Cao, Son Ngoc Nguyen, Anh Phuoc Lan Nguyen, Thoai Anh Nguyen, Sang Phu Bui, Trung Quang Le, Toan Hoang Ngo, Son Kim Tran

Open source

DOI: 10.1002/bcp.70654
Published: 2026-06-25
Container: British Journal of Clinical Pharmacology
Publisher: Wiley
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/bcp.70654,
  title = {Comparative effectiveness of dapagliflozin
                    <i>vs</i>
                    . empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real‐world prospective cohort study},
  author = {Tuong Le Trong Huynh and Hien Dieu Tran and Phong Thanh Pham and Nhan Dinh Tran and Nhan Thanh Nguyen and Huyen Doan Thi Bich Cao and Son Ngoc Nguyen and Anh Phuoc Lan Nguyen and Thoai Anh Nguyen and Sang Phu Bui and Trung Quang Le and Toan Hoang Ngo and Son Kim Tran},
  year = {2026},
  journal = {British Journal of Clinical Pharmacology},
  doi = {10.1002/bcp.70654},
  url = {https://doi.org/10.1002/bcp.70654}
}

RIS

TY  - JOUR
TI  - Comparative effectiveness of dapagliflozin
                    <i>vs</i>
                    . empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real‐world prospective cohort study
AU  - Tuong Le Trong Huynh
AU  - Hien Dieu Tran
AU  - Phong Thanh Pham
AU  - Nhan Dinh Tran
AU  - Nhan Thanh Nguyen
AU  - Huyen Doan Thi Bich Cao
AU  - Son Ngoc Nguyen
AU  - Anh Phuoc Lan Nguyen
AU  - Thoai Anh Nguyen
AU  - Sang Phu Bui
AU  - Trung Quang Le
AU  - Toan Hoang Ngo
AU  - Son Kim Tran
PY  - 2026
JO  - British Journal of Clinical Pharmacology
DO  - 10.1002/bcp.70654
UR  - https://doi.org/10.1002/bcp.70654
ER  -

APA

Huynh, T. L. T., Tran, H. D., Pham, P. T., Tran, N. D., Nguyen, N. T., Cao, H. D. T. B., Nguyen, S. N., Nguyen, A. P. L., Nguyen, T. A., Bui, S. P., Le, T. Q., Ngo, T. H., & Tran, S. K. (2026). Comparative effectiveness of dapagliflozin <i>vs</i> . empagliflozin on major adverse cardiovascular events in patients with heart failure with reduced ejection fraction: A real‐world prospective cohort study. British Journal of Clinical Pharmacology. https://doi.org/10.1002/bcp.70654

Source records

crossref · retrieved 2026-09-26T20:15:47.538Z